C4 Therapeutics, Inc. (CCCC)
3.14
+0.29
(+10.18%)
USD |
NASDAQ |
Oct 09, 14:29
C4 Therapeutics Price : 3.14 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 2.80 | 2.88 | 2.721 | 2.85 | 2.828M |
| Oct 07, 2026 | 2.85 | 2.95 | 2.82 | 2.82 | 2.268M |
| Oct 06, 2026 | 3.02 | 3.03 | 2.79 | 2.88 | 2.114M |
| Oct 05, 2026 | 3.01 | 3.10 | 2.95 | 2.99 | 1.464M |
| Oct 02, 2026 | 3.19 | 3.33 | 2.93 | 2.95 | 3.385M |
| Oct 01, 2026 | 3.31 | 3.37 | 3.135 | 3.14 | 1.892M |
| Sep 30, 2026 | 3.16 | 3.37 | 3.13 | 3.33 | 2.609M |
| Sep 29, 2026 | 3.09 | 3.215 | 3.00 | 3.13 | 1.554M |
| Sep 28, 2026 | 3.015 | 3.16 | 2.98 | 3.115 | 2.779M |
| Sep 25, 2026 | 3.03 | 3.115 | 2.925 | 2.98 | 2.119M |
| Sep 24, 2026 | 3.03 | 3.06 | 2.88 | 3.03 | 2.808M |
| Sep 23, 2026 | 3.32 | 3.34 | 2.925 | 3.08 | 4.595M |
| Sep 22, 2026 | 3.33 | 3.42 | 3.285 | 3.31 | 1.358M |
| Sep 21, 2026 | 3.44 | 3.45 | 3.245 | 3.30 | 2.051M |
| Sep 18, 2026 | 3.43 | 3.475 | 3.38 | 3.39 | 1.631M |
| Sep 17, 2026 | 3.51 | 3.59 | 3.40 | 3.415 | 1.758M |
| Sep 16, 2026 | 3.44 | 3.53 | 3.425 | 3.45 | 2.321M |
| Sep 15, 2026 | 3.40 | 3.455 | 3.32 | 3.43 | 1.345M |
| Sep 14, 2026 | 3.46 | 3.54 | 3.41 | 3.43 | 1.486M |
| Sep 11, 2026 | 3.475 | 3.525 | 3.355 | 3.51 | 1.482M |
| Sep 10, 2026 | 3.40 | 3.41 | 3.31 | 3.40 | 1.168M |
| Sep 09, 2026 | 3.54 | 3.54 | 3.42 | 3.44 | 1.442M |
| Sep 08, 2026 | 3.72 | 3.735 | 3.55 | 3.55 | 2.175M |
| Sep 04, 2026 | 3.72 | 3.845 | 3.660 | 3.76 | 2.363M |
| Sep 03, 2026 | 3.83 | 3.85 | 3.70 | 3.74 | 2.228M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 13.10 |
| Arrowhead Pharmaceuticals, Inc. | 62.55 |
| Oncolytics Biotech, Inc. | 0.557 |
| Sangamo Therapeutics, Inc. | 0.1401 |
| Sarepta Therapeutics, Inc. | 17.93 |
Price Related Metrics
| PS Ratio | 9.995 |
| Price to Book Value | 1.561 |
| Earnings Yield | -31.81% |
| Market Cap | 385.92M |